| Typ : |
Noviny |
| Internetový odkaz : |
https://doi.org/10.1007/s40259-019-00342-9 |
|
| Výzkumné týmy : |
Grenade - Faculty of Science, Department of Analytical Chemistry |
| Autor : |
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. |
| Titul : |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). |
| Référence : |
Bio Drugs ; 33: 193–205. 2019 |
|
| Úroveň důkazu : |
|
| Fyzikální stabilita : |
|
| Chemická stabilita : |
|
| Jiné metody : |
|
| Komentáře : |
| Bílkoviny: biologická aktivita buněčné kultury |
|
Seznamy
 Infliximab
|
 |
 |
 |
 |
10 mg/ml |
2-8°C |
 |
| 14 |
 |
|
|
|
|
|
10 mg/ml |
2-8°C |
|
| 14 |
|
|
 |
|
 |
 |
0,4 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
|
0,4 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
